R2R01 not checked

River 2 Renal Corp.

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 2 trial completes
Trials
2 active
3 in total · 2 in the EU

What this is

How it works
How it works isn't classified yet
How it’s given
“Pharmaceutical form: sterile 2R vials containing 10 mg of R2R01.”In the company’s words, NCT05875948 on ClinicalTrials.gov
Tested for
Acute Kidney Injury (2 trials), Hepatorenal Syndrome
Main trialPhase 2
“This study aims to evaluate the safety, tolerability and efficacy of R2R01 combined with terlipressin as compared to terlipressin alone in the treatment of patients with HRS-AKI”In the company’s words, NCT05875948 on ClinicalTrials.gov

Other drugs for Acute Kidney Injury

All 9 drugs for Acute Kidney Injury

Coming up1

Changes1

Last 90 days

Trials3

TrialPhaseCompletesWhat it tests
Phase 2Recruiting Dec 2024 Study to Evaluate R2R01 Plus Terlipressin Versus Terlipressin Alone in Patients With Hepatorenal Syndrome
Phase 2Recruiting 1 Apr 2027 Study of the Relaxin Agonist R2R01 in Patients at High Risk for Cardiac Surgery Associated- Acute Kidney Injury
Phase 2Completed 4 Nov 2024 To Evaluate the Safety, Tolerability and Efficacy of R2R01 Combined With SOC as Compared to SOC Alone in Outpatients With Worsening Heart Failure (WHF)
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow R2R01

Following is part of Solo: you see every change to R2R01 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in